Hyperbaric ozone therapy: scientific considerations [abstract]

Autors/ores

  • Robert Jay Rowen

DOI:

https://doi.org/10.7203/jo3t.3.4.2019.15534

Paraules clau:

hyperbaric ozone therapy

Resum

BACKGROUND: This ozone world is little familiar with a modification of major autohemotherapy called hyperbaric ozone therapy (HBO3). This method may be a superior delivery system of ozone therapy, capturing benefits of intravenous oxygen gas as well as the oxidizing power of ozone therapy. MATERIAL and METHODS: I will discuss a scientific comparison between the largely reviled direct intravenous ozone administration and HBO3, inclusive of a safety/efficacy survey of practicing HBO3 physicians in America.

Descàrregues

Les dades de descàrrega encara no estan disponibles.

Referències

Schmidt, H. [Regelsberger's intravenous oxygen therapy-an interpretation of results in practice from a biochemical and physiological point of view]. Forsch Komplementarmed Klass Naturheilkd. 2002;9(1):7-18.

Descàrregues

Publicades

2019-12-19

Com citar

Rowen, R. J. (2019). Hyperbaric ozone therapy: scientific considerations [abstract]. Journal of Ozone Therapy, 3(4), 54. https://doi.org/10.7203/jo3t.3.4.2019.15534
Metrics
Views/Downloads
  • Resum
    539
  • PDF
    291

Número

Vol. 3 No 4 (2019)

Secció

Proceedings

Llicència

Journal of Ozone Therapy applies the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC 4.0) license to works we publish.

Creative Commons License

Under this license, authors retain ownership of the copyright for their content, but allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. No permission is required from the authors or the publishers.
You may not use the material for commercial purposes.

Appropriate attribution can be provided by simply citing the original article, provide a link to the license, and indicate if changes were made.
You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Metrics